Pages that link to "Q41456449"

The following pages link to Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection (Q41456449):

Displaying 34 items.

• Yersinia pestis CO92 delta yopH is a potent live, attenuated plague vaccine (Q24672915) (← links)
• Cationic liposome-hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens (Q27310007) (← links)
• Plague Vaccine Development: Current Research and Future Trends (Q28066875) (← links)
• Principles of antidote pharmacology: an update on prophylaxis, post‐exposure treatment recommendations and research initiatives for biological agents (Q28384852) (← links)
• Nasal delivery of Protollin-adjuvanted H5N1 vaccine induces enhanced systemic as well as mucosal immunity in mice (Q30401917) (← links)
• NERVE: new enhanced reverse vaccinology environment (Q33250601) (← links)
• Immune defense against pneumonic plague (Q33584403) (← links)
• Mucosally delivered Salmonella typhi expressing the Yersinia pestis F1 antigen elicits mucosal and systemic immunity early in life and primes the neonatal immune system for a vigorous anamnestic response to parenteral F1 boost (Q33824782) (← links)
• Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid (Q34123275) (← links)
• Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP. (Q35688976) (← links)
• A comparison of immunogenicity and protective immunity against experimental plague by intranasal and/or combined with oral immunization of mice with attenuated Salmonella serovar Typhimurium expressing secreted Yersinia pestis F1 and V antigen (Q36237899) (← links)
• Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205/CD205 receptor (Q36288336) (← links)
• Current challenges in the development of vaccines for pneumonic plague (Q36628038) (← links)
• Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts. (Q36804213) (← links)
• FGL chaperone-assembled fimbrial polyadhesins: anti-immune armament of Gram-negative bacterial pathogens (Q36852090) (← links)
• Lipid A mimetics are potent adjuvants for an intranasal pneumonic plague vaccine (Q36960814) (← links)
• A Recombinant Trivalent Fusion Protein F1-LcrV-HSP70(II) Augments Humoral and Cellular Immune Responses and Imparts Full Protection against Yersinia pestis (Q37064828) (← links)
• Nanotechnology in vaccine delivery (Q37104199) (← links)
• Induction of mucosal immunity through systemic immunization: Phantom or reality? (Q37130744) (← links)
• Different pathologies but equal levels of responsiveness to the recombinant F1 and V antigen vaccine and ciprofloxacin in a murine model of plague caused by small- and large-particle aerosols. (Q37144984) (← links)
• Protective immunity in mice achieved with dry powder formulation and alternative delivery of plague F1-V vaccine (Q37190877) (← links)
• Prospects for new plague vaccines. (Q37640118) (← links)
• Adhesive organelles of Gram-negative pathogens assembled with the classical chaperone/usher machinery: structure and function from a clinical standpoint (Q37673260) (← links)
• Plague: Infections of Companion Animals and Opportunities for Intervention (Q38612499) (← links)
• Plague Vaccines: Status and Future (Q38813137) (← links)
• TLR2 activation by proteosomes promotes uptake of particulate vaccines at mucosal surfaces (Q40117050) (← links)
• Construction and screening of attenuated ΔphoP/Q Salmonella typhimurium vectored plague vaccine candidates (Q41418787) (← links)
• Validation of quantitative ELISAS for measuring anti-Yersinia pestis F1 and V antibody concentrations in nonhuman primate sera (Q41421634) (← links)
• Recombinant (F1+V) vaccine protects cynomolgus macaques against pneumonic plague. (Q41428963) (← links)
• Purification and characterization of Yersinia enterocolitica and Yersinia pestis LcrV-cholera toxin A(2)/B chimeras (Q41434206) (← links)
• Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270. (Q41435811) (← links)
• Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis (Q41445750) (← links)
• An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge (Q41452415) (← links)
• Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in mice (Q80641045) (← links)